Personalizing Therapy for Patients With CML

Michael J. Mauro, MD

Video Categories: CML

Dr. Mauro addresses the debate over selecting first line therapy with three approved agents available.

Related Videos

January 30, 2014

Defining Personalized Medicine in Melanoma and Cutaneous Malignancies

Listen as Dr Agarwala describes the nuances of personalized medicine as they relate to melanoma and cutaneous malignancies.

April 14, 2015

The bioT3 Platform

Dr. Boccia describes the components of the bioT3 platform and its clinical utility in identifying tumor type and actionable targets for therapy.